Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

pH-controlled recovery of placenta-derived mesenchymal stem cell sheets.

Guillaume-Gentil O, Semenov OV, Zisch AH, Zimmermann R, Vörös J, Ehrbar M.

Biomaterials. 2011 Jul;32(19):4376-84. doi: 10.1016/j.biomaterials.2011.02.058. Epub 2011 Apr 1.

PMID:
21458856
2.

Biological and physicochemical characterization of a serum- and xeno-free chemically defined cryopreservation procedure for adult human progenitor cells.

Zeisberger SM, Schulz JC, Mairhofer M, Ponsaerts P, Wouters G, Doerr D, Katsen-Globa A, Ehrbar M, Hescheler J, Hoerstrup SP, Zisch AH, Kolbus A, Zimmermann H.

Cell Transplant. 2011;20(8):1241-57. doi: 10.3727/096368910X547426. Epub 2010 Dec 22.

PMID:
21176408
3.

Optimization of the culturing conditions of human umbilical cord blood-derived endothelial colony-forming cells under xeno-free conditions applying a transcriptomic approach.

Zeisberger SM, Zoller S, Riegel M, Chen S, Krenning G, Harmsen MC, Sachinidis A, Zisch AH.

Genes Cells. 2010 Jun;15(7):671-87. doi: 10.1111/j.1365-2443.2010.01409.x. Epub 2010 May 20.

4.

Injectable candidate sealants for fetal membrane repair: bonding and toxicity in vitro.

Bilic G, Brubaker C, Messersmith PB, Mallik AS, Quinn TM, Haller C, Done E, Gucciardo L, Zeisberger SM, Zimmermann R, Deprest J, Zisch AH.

Am J Obstet Gynecol. 2010 Jan;202(1):85.e1-9. doi: 10.1016/j.ajog.2009.07.051.

5.

Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation.

Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, Zisch AH, Malek A.

Am J Obstet Gynecol. 2010 Feb;202(2):193.e1-193.e13. doi: 10.1016/j.ajog.2009.10.869. Epub 2009 Dec 24.

PMID:
20035913
6.

Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics.

Lucchinetti E, Zeisberger SM, Baruscotti I, Wacker J, Feng J, Zaugg K, Dubey R, Zisch AH, Zaugg M.

Anesth Analg. 2009 Oct;109(4):1117-26. doi: 10.1213/ANE.0b013e3181b5a277.

PMID:
19762739
7.

Engineered polyelectrolyte multilayer substrates for adhesion, proliferation, and differentiation of human mesenchymal stem cells.

Semenov OV, Malek A, Bittermann AG, Vörös J, Zisch AH.

Tissue Eng Part A. 2009 Oct;15(10):2977-90. doi: 10.1089/ten.TEA.2008.0602.

PMID:
19320572
8.

Relation between mechanical properties and microstructure of human fetal membranes: an attempt towards a quantitative analysis.

Jabareen M, Mallik AS, Bilic G, Zisch AH, Mazza E.

Eur J Obstet Gynecol Reprod Biol. 2009 May;144 Suppl 1:S134-41. doi: 10.1016/j.ejogrb.2009.02.032. Epub 2009 Mar 17.

PMID:
19282091
9.

Decreased umbilical artery compliance and igf-I plasma levels in infants with intrauterine growth restriction - implications for fetal programming of hypertension.

Burkhardt T, Matter CM, Lohmann C, Cai H, Lüscher TF, Zisch AH, Beinder E.

Placenta. 2009 Feb;30(2):136-41. doi: 10.1016/j.placenta.2008.11.005. Epub 2008 Dec 13.

PMID:
19070892
10.

Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy.

Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH.

Cell Transplant. 2008;17(8):955-68.

11.

Bioengineering of foetal membrane repair.

Zisch AH, Zimmermann R.

Swiss Med Wkly. 2008 Oct 18;138(41-42):596-601. doi: 2008/41/smw-11997. Review.

12.

The dosage dependence of VEGF stimulation on scaffold neovascularisation.

Davies N, Dobner S, Bezuidenhout D, Schmidt C, Beck M, Zisch AH, Zilla P.

Biomaterials. 2008 Sep;29(26):3531-8. doi: 10.1016/j.biomaterials.2008.05.007. Epub 2008 Jun 9.

PMID:
18541296
13.

The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis.

Ehrbar M, Zeisberger SM, Raeber GP, Hubbell JA, Schnell C, Zisch AH.

Biomaterials. 2008 Apr;29(11):1720-9. Epub 2007 Dec 26.

14.

Fetoscopic closure of punctured fetal membranes with acellular human amnion plugs in a rabbit model.

Mallik AS, Fichter MA, Rieder S, Bilic G, Stergioula S, Henke J, Schneider KT, Kurmanavicius J, Biemer E, Zimmermann R, Zisch AH, Papadopulos NA.

Obstet Gynecol. 2007 Nov;110(5):1121-9.

PMID:
17978128
15.

Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering.

Ehrbar M, Rizzi SC, Hlushchuk R, Djonov V, Zisch AH, Hubbell JA, Weber FE, Lutolf MP.

Biomaterials. 2007 Sep;28(26):3856-66. Epub 2007 Apr 5.

PMID:
17568666
16.

EphA4 signaling regulates phospholipase Cgamma1 activation, cofilin membrane association, and dendritic spine morphology.

Zhou L, Martinez SJ, Haber M, Jones EV, Bouvier D, Doucet G, Corera AT, Fon EA, Zisch AH, Murai KK.

J Neurosci. 2007 May 9;27(19):5127-38.

17.

Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model.

Walpoth BH, Zammaretti P, Cikirikcioglu M, Khabiri E, Djebaili MK, Pache JC, Tille JC, Aggoun Y, Morel D, Kalangos A, Hubbell JA, Zisch AH.

J Thorac Cardiovasc Surg. 2007 May;133(5):1163-70.

18.

Engineering and differentiation of stem cell sheets.

Semenov O, Voros J, Zisch A.

J Stem Cells Regen Med. 2007 May 16;2(1):145. eCollection 2007. No abstract available.

PMID:
24692961
19.

Engineering and differentiation of stem cell sheets.

Semenov O, Voros J, Zisch A.

J Stem Cells Regen Med. 2007 May 16;2(1):134. eCollection 2007. No abstract available.

PMID:
24692953
20.

MnSOD marks cord blood late outgrowth endothelial cells and accompanies robust resistance to oxidative stress.

Cai H, Gehrig P, Scott TM, Zimmermann R, Schlapbach R, Zisch AH.

Biochem Biophys Res Commun. 2006 Nov 17;350(2):364-9. Epub 2006 Sep 20.

PMID:
17010941
21.

PPS-PEG surface coating to reduce thrombogenicity of small diameter ePTFE vascular grafts.

Karrer L, Duwe J, Zisch AH, Khabiri E, Cikirikcioglu M, Napoli A, Goessl A, Schaffner T, Hess OM, Carrel T, Kalangos A, Hubbell JA, Walpoth BH.

Int J Artif Organs. 2005 Oct;28(10):993-1002.

PMID:
16288437
22.

Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism.

Helm CL, Fleury ME, Zisch AH, Boschetti F, Swartz MA.

Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15779-84. Epub 2005 Oct 25.

23.

Effects of protein and gene transfer of the angiopoietin-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization.

Weber CC, Cai H, Ehrbar M, Kubota H, Martiny-Baron G, Weber W, Djonov V, Weber E, Mallik AS, Fussenegger M, Frei K, Hubbell JA, Zisch AH.

J Biol Chem. 2005 Jun 10;280(23):22445-53. Epub 2005 Mar 21.

24.

Adult 'endothelial progenitor cells'. Renewing vasculature.

Zammaretti P, Zisch AH.

Int J Biochem Cell Biol. 2005 Mar;37(3):493-503. Review.

PMID:
15618004
25.

Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity.

Ehrbar M, Metters A, Zammaretti P, Hubbell JA, Zisch AH.

J Control Release. 2005 Jan 3;101(1-3):93-109.

PMID:
15588897
26.

Broad-spectrum protein biosensors for class-specific detection of antibiotics.

Weber CC, Link N, Fux C, Zisch AH, Weber W, Fussenegger M.

Biotechnol Bioeng. 2005 Jan 5;89(1):9-17.

PMID:
15580576
27.

Tissue engineering of angiogenesis with autologous endothelial progenitor cells.

Zisch AH.

Curr Opin Biotechnol. 2004 Oct;15(5):424-9. Review.

PMID:
15464372
28.

Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth.

Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-Baron G, Schenk U, Wood J, Burri PH, Hubbell JA, Zisch AH.

Circ Res. 2004 Apr 30;94(8):1124-32. Epub 2004 Mar 25.

PMID:
15044320
29.

MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing.

Seliktar D, Zisch AH, Lutolf MP, Wrana JL, Hubbell JA.

J Biomed Mater Res A. 2004 Mar 15;68(4):704-16.

PMID:
14986325
30.

Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2.

Zisch AH, Zeisberger SM, Ehrbar M, Djonov V, Weber CC, Ziemiecki A, Pasquale EB, Hubbell JA.

Biomaterials. 2004 Jul;25(16):3245-57.

PMID:
14980419
31.

Biopolymeric delivery matrices for angiogenic growth factors.

Zisch AH, Lutolf MP, Hubbell JA.

Cardiovasc Pathol. 2003 Nov-Dec;12(6):295-310. Review.

PMID:
14630296
32.

Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth.

Zisch AH, Lutolf MP, Ehrbar M, Raeber GP, Rizzi SC, Davies N, Schmökel H, Bezuidenhout D, Djonov V, Zilla P, Hubbell JA.

FASEB J. 2003 Dec;17(15):2260-2. Epub 2003 Oct 16.

PMID:
14563693
33.

Conditional human VEGF-mediated vascularization in chicken embryos using a novel temperature-inducible gene regulation (TIGR) system.

Weber W, Marty RR, Link N, Ehrbar M, Keller B, Weber CC, Zisch AH, Heinzen C, Djonov V, Fussenegger M.

Nucleic Acids Res. 2003 Jun 15;31(12):e69.

34.

Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.

Yu HH, Zisch AH, Dodelet VC, Pasquale EB.

Oncogene. 2001 Jul 5;20(30):3995-4006.

35.

Covalently conjugated VEGF--fibrin matrices for endothelialization.

Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA.

J Control Release. 2001 May 14;72(1-3):101-13.

PMID:
11389989
36.

The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2.

Barritt DS, Pearn MT, Zisch AH, Lee SS, Javier RT, Pasquale EB, Stallcup WB.

J Cell Biochem. 2000 Aug 2;79(2):213-24.

37.

Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.

Zisch AH, Pazzagli C, Freeman AL, Schneller M, Hadman M, Smith JW, Ruoslahti E, Pasquale EB.

Oncogene. 2000 Jan 13;19(2):177-87.

38.

An Eph receptor regulates integrin activity through R-Ras.

Zou JX, Wang B, Kalo MS, Zisch AH, Pasquale EB, Ruoslahti E.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13813-8.

39.

A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A.

Dodelet VC, Pazzagli C, Zisch AH, Hauser CA, Pasquale EB.

J Biol Chem. 1999 Nov 5;274(45):31941-6.

40.
41.

The Eph family: a multitude of receptors that mediate cell recognition signals.

Zisch AH, Pasquale EB.

Cell Tissue Res. 1997 Nov;290(2):217-26. Review.

PMID:
9321683
42.

Tyrosine phosphorylation of L1 family adhesion molecules: implication of the Eph kinase Cek5.

Zisch AH, Stallcup WB, Chong LD, Dahlin-Huppe K, Voshol J, Schachner M, Pasquale EB.

J Neurosci Res. 1997 Mar 15;47(6):655-65.

PMID:
9089215
43.

The glypiated neuronal cell adhesion molecule contactin/F11 complexes with src-family protein tyrosine kinase Fyn.

Zisch AH, D'Alessandri L, Amrein K, Ranscht B, Winterhalter KH, Vaughan L.

Mol Cell Neurosci. 1995 Jun;6(3):263-79.

PMID:
7496631
44.

Tenascin-contactin/F11 interactions: a clue for a developmental role?

Vaughan L, Weber P, D'Alessandri L, Zisch AH, Winterhalter KH.

Perspect Dev Neurobiol. 1994;2(1):43-52. Review.

PMID:
7530143
45.

Cellular receptors for tenascin.

Vaughan L, Zisch AH, Weber P, D'Allesandri L, Ferber P, David G, Zimmermann DR, Winterhalter KH.

Contrib Nephrol. 1994;107:80-4. No abstract available.

PMID:
7516276
46.

Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its immunoglobulin-like domains.

Zisch AH, D'Alessandri L, Ranscht B, Falchetto R, Winterhalter KH, Vaughan L.

J Cell Biol. 1992 Oct;119(1):203-13.

Supplemental Content

Loading ...
Support Center